CLL | Tumor

CURE’s Chronic Lymphocytic Leukemia (CLL) page features the latest cancer news and updates on CLL Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in chronic lymphocytic leukemia.

Positive Data Stops Phase 3 CLL Study of Zydelig

November 19th 2015

A phase 3 study exploring Zydelig in combination with Treanda and Rituxan for patients with previously treated CLL has been stopped early following a positive interim analysis.

Diagnosis: CLL

November 4th 2015

Ed chronicles his chronic lymphocytic leukemia (CLL) story from the third person.

Connecting Healthy Adults to People With Blood Cancers

October 15th 2015

By donating stem cells through Be The Match, healthy adults can save the lives of people with blood cancers.

New Treatments May Be Worth the Wait in CLL

August 21st 2015

Watching, waiting and then choosing from a bevy of new treatments can be a good strategy for many with CLL.

FDA Submission of Phase 2 Data Planned for Venetoclax in CLL

August 15th 2015

The investigational agent venetoclax has successfully met the primary endpoint of a phase 2 study as a treatment for patients with high-risk relapsed or refractory chronic lymphocytic leukemia.

Time to Progression in CLL Improves 80 Percent with Imbruvica Plus Standard Drugs

June 2nd 2015

Adding the targeted drug Imbruvica to a standard combination treatment reduced the risk of disease progression by 80 percent compared with the standard combination alone in patients with pretreated CLL or SLL.

Telephone Intervention Reduces Unplanned Hospital Visits for Patients With Blood Cancers

May 6th 2015

A navigator-designed, proactive, weekly, telephone support call to help patients with blood cancers manage their symptoms between appointments was able to significantly reduce unplanned hospitalizations at a Colorado cancer center.

Eliminating Chemotherapy in the Treatment of CLL

April 29th 2015

The efficacy of Imbruvica (ibrutinib) and Zydelig (idelalisib) in chronic lymphocytic leukemia (CLL) suggests the drugs could potentially replace chemoimmunotherapy completely for some patients.

ASCO Selects Dramatic Improvement in CLL Care as 'Cancer Advance of the Year'

January 21st 2015

The vastly improved outlook for patients with chronic lymphocytic leukemia (CLL) was named the American Society of Clinical Oncology's inaugural "Cancer Advance of the Year."

FDA Updates Gazyva Label for Frontline Chronic Lymphocytic Leukemia

December 27th 2014

The FDA has updated the label for Gazyva (obinutuzumab) plus chlorambucil to include data from stage 2 of the phase 3 CLL11 study, which detailed an improvement in progression-free survival as a frontline treatment for patients with chronic lymphocytic leukemia.

Zydelig Yields High Responses in Older Patients with Newly Diagnosed CLL, SLL

December 9th 2014

Zydelig was approved for several recurrent B-cell cancers, and now new data shows the drug also creates a response in older patients newly diagnosed with CLL or SLL.

Treatments for Follicular Lymphoma Continue to Evolve

November 15th 2014

Approved and investigational agents have improved outcomes for patients with follicular lymphoma; however a growing understanding of the origins and progression of the disease might offer further insights for future clinical development.


September 25th 2014

The latest in cancer prevention, diagnosis and treatment.

Newly Approved Gazyva May Become Standard in Older, Sicker Patients with Chronic Lymphocytic Leukemia

December 13th 2013

Gazyva may become a standard treatment for older, sicker patient with CLL.

ASH Updates

December 8th 2013

Updates from the annual meeting of the American Society of Hematology.


March 14th 2013

The latest in cancer prevention, diagnosis & treatment.

Taking a Chance on Stem Cell Transplantation

December 17th 2012

When considering a stem cell transplantation, patients with cancer must be willing to take a chance.

Investigational Drug Shows Benefit in CLL

January 5th 2012

In an early-phase study, PCI-32765, a BTK inhibitor, was shown to work against CLL, a type of non-Hodgkin lymphoma.

Treatment Updates

December 20th 2010

Updates from the annual meetings of the American Society of Hematology and the San Antonio Breast Cancer Symposium.

Other Leukemias

June 6th 2010

Leukemia is more than just one disease.

Progress That's Worth the Wait

June 5th 2010

A wave of new treatments for chronic lymphocytic leukemia can help keep the disease at bay.


March 14th 2010

The latest in cancer prevention, diagnosis, and treatment.

Drug Therapies

December 23rd 2009

Drug news and recent developments

What's New with Stem Cell Transplants?

October 26th 2009

Advances in stem cell transplantation leads to a changing landscape in treating blood cancers, such as lymphoma, leukemia, and multiple myeloma.

My Extended Vacation

March 13th 2009

The Leukemia and Lymphoma Society's "First Connection" program connects volunteers with newly diagnosed patients and caregivers to help them manage the many aspects of a cancer diagnosis.

Medicine's New Epicenter? Epigenetics

December 9th 2008

Flipping cancer's "off" switch.

Treatment Updates

December 9th 2008

News updates from the American Society of Hematology and the San Antonio Breast Cancer Symposium.

Multiple Myeloma & Thrombocytopenia

September 8th 2008

Velcade is now available for newly diagnosed multiple myeloma patients and new drugs emerge as potential treatment to a serious side effect.

CLL & Constipation

June 12th 2008

Discussion of new drugs for CLL and to relieve constipation.

Mistaken Identity

December 11th 2007

Preventing misdiagnoses of blood cancers is all in the details.